研究機構:內地「雙11」智能手機銷售按年增長5%
市場研究機構Counterpoint Research指,內地「雙11」購物節的兩個星期,智能手機銷售按年增長5%,為第四季的正面表現提供信心,華為、小米(01810.HK)及榮耀繼續推動強勁增長,被壓抑的需求釋放,為市場提供支持。
「雙11」期間,蘋果iPhone手機以近25%的市場份額,位列中國市場榜首,不過銷售額按年跌4%。
小米及榮耀的銷售額分別按年升28%及11%,市佔率排名第二及第三;華為銷售額按年大升66%。
研究機構指,華為銷售強勁,主要因為最近推出Mate 60系列5G手機,以及舊款P系列4G手機普及,但增長數據存在基數效應,預期華為全年銷售有望增長一半以上,但與疫情前仍有差距。(cy/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.